Remove keyword drug-safety
article thumbnail

Overview of FDA Expedited Development and Approval Programs for Serious Conditions

Impact Pharmaceutical Services

In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Category: Regulatory Affairs , Drug Development Consulting.

FDA 52
article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

NAMPT inhibitors are a class of drugs that target the enzyme nicotinamide phosphoribosyltransferase (NAMPT). One of the main challenges is the development of drug resistance, as cancer cells can develop mechanisms to bypass the inhibition of NAMPT. Several trials focused on evaluation of such drugs were discontinued in the past.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma

ISPE

But can we imagine applying a tool like ChatGPT in a safety-critical, product-related environment? ChatGPT : “Yes, ChatGPT can be useful in regulated areas of the pharmaceutical industry, such as providing information on drug products, their uses, dos-ages, side effects, and interactions with other medications. The Keyword.

article thumbnail

Five Things To Know: How To Use Artificial Intelligence To Be A Better Clinical Pharmacist

IDStewardship

Pharmacists aim to ensure medication safety and efficacy—a goal that involves diverse tasks across different settings, often requiring skills beyond traditional pharmacy knowledge. Drug references & literature review AI is transforming the pharmacists’ approach to essential tasks like using drug references and literature reviews.